Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |